Bristol Myers Squibb (BMS) Korea presented a patient-specific treatment, utilizing its psoriasis drug, Sotyktu (deucravacitinib), in a media session in Seoul on Thursday. Psoriasis is a chronic, non-infectious skin disease with repeated flare-ups and remissions.According to Bang Chul-hwan, professor
The Korean Health Industry Development Institute (KHIDI) said it has started accepting applications from Korean healthcare companies that want to move into its Boston Connect and Development (C&D) Incubation Office, located within the Cambridge Innovation Center (CIC) in Boston, Mass. KHIDI will acc
Samsung Biologics on Wednesday reported last year’s consolidated sales of 3.69 trillion won ($2.76 billion) and operating profit of 1.11 trillion won.This represents a 23.1 percent year-on-year increase in sales and a 13.2 percent increase in operating profit compared to those in 2022.It is the firs
PharmAbcine said Wednesday that the company began the administration of its VISTA-targeted immunotherapy candidate, PMC-309, in patients in Australia.The Australian phase 1a/b trial will be conducted on 67 patients with advanced or metastatic solid tumors at four medical institutions.According to Ph
JW Shinyak, a Kosdaq-listed biotech company, said Wednesday that it has started selling Ducray Neoptide Expert, Pierre Fabre’s hair loss relief cosmetic.Ducray Neoptide Expert is a specialized cosmetic for hair loss relief developed through clinical trials and is available at medical institutes for
Boehringer Ingelheim Korea said it has appointed Ana-Maria Boie as the new general manager (GM) and head of human pharma, effective from Jan. 15.According to the company, Ana-Maria Boie, the newly appointed GM, has worked in the pharmaceutical industry for 24 years and has amassed expertise in manag
Celltrion said Wednesday that it has signed a business agreement with WuXi XDC, a Chinese company specializing in antibody-drug conjugates (ADCs), to strengthen ADC drug development and to begin developing drugs for contract development and manufacturing organizations (CDMOs).WuXi XDC, a joint compa
Dong-A ST said it has partnered with the Korea Institute of Science and Technology (KIST) to develop a novel treatment for inflammatory bowel disease (IBD).Under the accord, Dong-A ST will acquire the patent rights for the oral nucleic acid therapy delivery technology developed by KIST's Biomedical
Hyundai Pharmaceutical said Tuesday that it has launched Complex Minoxyl Solution 240ml (minoxidil), a hair loss treatment containing vitamins and other scalp care ingredients.Complex Minoxyl Solution is a product that adds two vitamin ingredients, vitamin B6 (pyridoxine hydrochloride) and vitamin E
Ildong Pharmaceutical improved its profitability in the company’s performance results for 2023.Ildong Pharm disclosed its preliminary performance results for 2023 through a public announcement on Monday. The bottom lines showed that the company showed positive changes in operating income and net inc
AriBio, primarily known for its work to develop an oral Alzheimer's disease treatment candidate, has been penalized for the sale of cosmetics containing ingredients that are not permitted for use.The Ministry of Food and Drug Safety issued the penalty last Thursday, mandating a three-month suspensio
AbClon said Monday that AC101 (HLX in Chinese code name), licensed to Shanghai Henlius Biotech, has demonstrated potential as a first-line treatment for patients with HER2-positive gastric cancer in a phase 2 clinical trial.Henlius released interim results from the ongoing phase 2 clinical trial of
Merck Korea said it launched its Fertility Benefit Program for its employees and their spouses, effective from Jan. 1 this year.Merck Korea has about 1,750 employees, according to its website. The program, part of Merck's broader initiative "Fertility Counts," is designed to support the reproductive
Hanmi Pharm said that its combination antihypertensive drug, Amosartan Tab, has recorded cumulative sales of 1.05 trillion won ($786.2 million) as of December last year. The record was achieved more than 14 years after its launch, with sales averaging 75 billion won per year.Amosartan is a drug that
NeoImmuneTech, a Kosdaq-listed T-cell-based immunotherapy developer, said Monday that its pancreatic cancer drug, NT-I7 (efineptakin alfa), has received an orphan drug designation (ODD) from the U.S. FDA.The FDA's ODD system is designed to facilitate the development and approval of drugs to treat ra
Hanmi Pharm said Friday that the cumulative sales of Mok-N Spray, an over-the-counter drug for treating sore throat that was first launched in 2015, exceeded 3.91 million units.Mok-N sold more than 210,000 units in 2015, the first year of its launch, and it began to grow rapidly from the beginning o
GC Biopharma said that the intracerebroventricular (ICV) enzyme replacement therapy (ERT) drug for Sanfilippo Syndrome Type A, jointly developed with Korean biotech venture Novel Pharma, has been designated as an orphan drug by the European Medicines Agency (EMA).The recognition follows the drug's p
JW Pharmaceutical said Thursday that the results of a study demonstrating various physical activity data and safety in patients taking Hemlibra (emicizumab) for hemophilia A were recently published in the International Journal of Hematology (Int J Hematol).Hemlibra is a breakthrough drug mimicking f
Dongwha Pharm said it acquired four over-the-counter (OTC) products from Celltrion, which the latter purchased from Takeda Pharmaceuticals in 2020, for about 37.2 billion won ($27.8 million).The transaction includes medications such as the comprehensive cold medicine Whituben and Whituben Nasal Spra
CanariaBio said the Data and Safety Monitoring Board (DSMB) recommended halting its global phase 3 clinical trial of oregovomab, an antibody targeting CA125, for ovarian cancer patients.The company said that the recommendation was made due to the trial not achieving the necessary statistical value (